FAKTOR-OPTIONSSCHEIN - RESMED | Market Closed - Bid/Ask 02:06:53 2024-05-20 EDT | Pre-market 02:20:41 | |||
| 1.57 EUR | -1.26% |
|
1.61 | +2.55% |
| Current month | -19.70% | ||
| 1 month | -85.60% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RESMED, INC.
Latest news about RESMED, INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-20 | 1.57 | -1.26% |
| 24-05-17 | 1.59 | +4.61% |
| 24-05-16 | 1.52 | +0.66% |
| 24-05-15 | 1.51 | -13.71% |
| 24-05-14 | 1.75 | +4.17% |
Delayed Quote Börse Stuttgart
Last update May 20, 2024 at 02:06 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | RESMED, INC. |
| Issuer | Morgan Stanley |
| WKN | MG2D1R |
| ISIN | DE000MG2D1R3 |
| Date issued | 2024-04-16 |
| Strike | 256.6 $ |
| Maturity | Unlimited |
| Parity | 21.95 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.71 € |
|---|---|
| Lowest since issue | 1.49 € |
| Spread | 0.08 € |
| Spread % | 4.85% |
Company Profile
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Sector
-
Consensus: ResMed, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
218.6
USD
Average target price
216.6
USD
Spread / Average Target
-0.88%
- Stock Market
- Certificates
- Certificat
